S E Rivkin
Overview
Explore the profile of S E Rivkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
821
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bukowski R, Tangen C, Peterson R, Taylor S, Rinehart J, Eyre H, et al.
Cancer
. 1994 Mar;
73(5):1505-8.
PMID: 8111718
Background: The use of chemotherapy in patients with metastatic carcinoid tumors has been of limited value, and investigation of new agents is necessary. Previous reports have suggested that dimethyltriazenoimidazole carboxamide...
12.
Rivkin S, Green S, Metch B, JEWELL W, COSTANZI J, Altman S, et al.
J Clin Oncol
. 1993 Sep;
11(9):1710-6.
PMID: 8355037
Purpose: To determine if prolonged adjuvant treatment (2 years v 1 year) with combination chemotherapy (cyclophosphamide, methotrexate, fluorouracil [5-FU], vincristine, and prednisone [CMFVP]) in poor-prognosis breast cancer patients (estrogen receptor...
13.
Blumenstein B, Crawford E, Saiers J, Stephens R, Rivkin S, COLTMAN Jr C
J Urol
. 1993 Aug;
150(2 Pt 1):411-3.
PMID: 8326565
In a Southwest Oncology Group phase II clinical trial, 68 patients with hormone refractory carcinoma of the prostate were treated with a combination of doxorubicin, mitomycin C and 5-fluorouracil. Of...
14.
Antman K, Crowley J, Balcerzak S, Rivkin S, Weiss G, Elias A, et al.
J Clin Oncol
. 1993 Jul;
11(7):1276-85.
PMID: 8315425
Purpose And Methods: Doxorubicin alone or with dacarbazine (DTIC; AD) is considered the best available therapy for metastatic adult sarcomas. Ifosfamide is active in sarcomas that have failed to respond...
15.
Wozniak A, Blumenstein B, Crawford E, Boileau M, Rivkin S, FLETCHER W
Cancer
. 1993 Jun;
71(12):3975-8.
PMID: 8508363
Background: Hormone-refractory metastatic prostate cancer remains a therapeutic challenge. Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF), a drug combination that is active in solid tumors, was evaluated using specific response criteria. Methods:...
16.
Harvey W, Fleming T, Goodman P, Harvey J, Rivkin S, Macdonald J
Invest New Drugs
. 1993 Feb;
11(1):45-6.
PMID: 8394295
No abstract available.
17.
Ravdin P, Green S, Dorr T, McGuire W, Fabian C, PUGH R, et al.
J Clin Oncol
. 1992 Aug;
10(8):1284-91.
PMID: 1634918
Purpose: Southwest Oncology Group (SWOG) protocol 8228 is a prospective trial designed to investigate the prognostic significance of progesterone receptor (PgR) levels in estrogen receptor (ER)-positive breast cancer patients who...
18.
Higano C, Goodman P, Craig J, KISH J, Rivkin S, Wolf M, et al.
Invest New Drugs
. 1991 Nov;
9(4):361-3.
PMID: 1804814
Twenty four patients with advanced renal cell carcinoma were treated in a phase II trial with amonafide 300-450 mg/m2/day on days 1-5 every 21 days. There were no responders, 6...
19.
Silver R, Case Jr D, Wheeler R, Miller T, Stein R, Stuart J, et al.
J Clin Oncol
. 1991 May;
9(5):754-61.
PMID: 2016617
In this phase II multicenter trial, the efficacy and safety of mitoxantrone (Novantrone; Lederle Laboratories, Wayne, NJ) were evaluated in the treatment of 206 patients with relapsed non-Hodgkin's lymphoma (NHL)...
20.
Goodman G, Crowley J, Livingston R, Rivkin S, Albain K, McCulloch J
J Clin Oncol
. 1991 Mar;
9(3):453-7.
PMID: 1847967
Between March 1986 and May 1988, the Southwest Oncology Group enrolled 58 previously untreated patients with limited small-cell lung cancer on a treatment program that administered high-dose cyclophosphamide (150 mg/kg)...